NCT07150793View on ClinicalTrials.gov

A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan

CompletedOBSERVATIONAL
Enrollment

754

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
Myeloid Leukemia, Chronic
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY